Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2017 Filed May 23, 2017 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 14,011 | $65.47 | $917,230.12 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,251 Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 700 | $65.46 | $45,822.00 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,262 Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 600 | $65.46 | $39,273.00 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,962 Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 600 | $65.45 | $39,270.00 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,562 Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $65.45 | $19,633.50 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,162 Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:13 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 500 | $65.44 | $32,720.00 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,462 Read SEC document |
| April 07, 2017 Filed May 9, 2017 17:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 4,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006925 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,781 Read SEC document |
| March 10, 2017 Filed Mar 10, 2017 17:20 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-004436 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,962 Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 17:20 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 53,650 | $0.00 Strike: $29.23 | $0.00 |
DisclosureSEC source: 0001179110-17-004436 · edgar.xml · derivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 53,650 shares Expires 2022-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 17:20 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 18,366 | $0.00 Strike: $24.21 | $0.00 |
DisclosureSEC source: 0001179110-17-004436 · edgar.xml · derivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 18,366 shares Expires 2021-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 17:20 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 72,016 | $64.25 | $4,627,028.00 |
DisclosureSEC source: 0001179110-17-004436 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,747 Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 17:20 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 53,650 | $29.23 | $1,568,001.73 |
DisclosureSEC source: 0001179110-17-004436 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 17:20 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 18,366 | $24.21 | $444,607.80 |
DisclosureSEC source: 0001179110-17-004436 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 18:11 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 112,867 | $62.22 | $7,022,584.74 |
DisclosureSEC source: 0001179110-17-003701 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,747 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:51 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 261,150 | $0.00 Strike: $61.36 | $0.00 |
DisclosureSEC source: 0001179110-17-002808 · edgar.xml · derivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,150 Underlying: Common stock · 261,150 shares Expires 2027-02-15 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 87,050 on 02/16/2018, 87,050 on 02/16/2019, and 87,050 on 02/16/2020. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:51 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 42,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002808 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,614 F2 · shares: Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:51 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 94,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002808 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,963 F1 · shares: Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 17:17 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon Stock, $0.01 par value | 8,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001673 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,166 Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 17:08 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon Stock, $0.01 par value | 3,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-032746 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,581 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption(right to buy) · Derivative | 285,953 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · derivative · entry 30 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 285,953 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,700 | $63.92 | $108,655.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,421 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 7,717 | $63.84 | $492,653.28 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,121 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 700 | $63.91 | $44,733.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 25 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,838 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,019 | $63.92 | $129,054.48 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 24 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,538 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 5,699 | $63.87 | $363,995.13 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 23 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,557 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 600 | $63.93 | $38,355.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 22 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,256 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 4,400 | $63.91 | $281,204.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 21 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,856 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 4,300 | $63.86 | $274,598.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 20 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,256 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,300 | $63.85 | $82,998.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,556 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 4,900 | $63.81 | $312,644.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,856 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 11,726 | $63.88 | $749,056.88 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,756 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,900 | $63.89 | $185,266.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,482 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 400 | $63.84 | $25,534.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,382 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,511 | $63.85 | $96,477.35 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,782 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,000 | $63.93 | $63,930.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,293 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 400 | $63.88 | $25,550.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,293 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 5,397 | $63.83 | $344,490.51 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,693 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 13,019 | $63.89 | $831,783.91 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,090 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 9,434 | $63.81 | $601,983.54 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,109 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,700 | $63.90 | $108,621.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,543 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $63.81 | $19,142.25 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,243 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 5,402 | $63.90 | $345,187.80 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,543 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,100 | $63.87 | $70,251.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,945 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 7,261 | $63.82 | $463,397.02 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,045 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 190,468 | $63.80 | $12,151,858.40 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,306 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 600 | $63.82 | $38,289.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623,774 Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 285,953 | $35.88 | $10,259,993.64 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,374 Read SEC document |
| May 11, 2016 Filed May 13, 2016 17:11 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 39,000 | $63.80 | $2,488,200.00 |
DisclosureSEC source: 0001179110-16-024608 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,421 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 17:20 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 89,311 | $56.00 | $5,001,416.00 |
DisclosureSEC source: 0001179110-16-020678 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,421 Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 17:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 255,170 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019779 · edgar.xml · derivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,170 Underlying: Common stock · 255,170 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 85,057 on 02/18/2017, 85,056 on 02/18/2018, and 85,057 on 02/18/2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.